In addition, a high-risk score constructed using YBX1, ZC3H13, YTHDF1, TRMT10C, YTHDF2, RRP8, TRMT6, LRPPRC, and IGF2BP3 was associated with poor prognosis, tumor grade, clinical stage, T stage, distant metastasis, and fustat status and is an independent risk factor for poor prognosis in HCC patients. The gene discussed is YTHDF2; the disease is hepatocellular carcinoma.